GOLDMAN SACHS GROUP INC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$114,264,692
+1.9%
4,210,195
+15.4%
0.02%0.0%
Q2 2023$112,110,502
+35.1%
3,647,056
+58.3%
0.02%
+27.8%
Q1 2023$82,989,520
+71.9%
2,303,345
+88.6%
0.02%
+63.6%
Q4 2022$48,272,059
-12.7%
1,221,459
-11.3%
0.01%
-15.4%
Q3 2022$55,316,000
+33.4%
1,376,705
+39.6%
0.01%
+44.4%
Q2 2022$41,473,000
-28.4%
986,527
-33.7%
0.01%
-25.0%
Q1 2022$57,958,000
+11.4%
1,487,630
+13.9%
0.01%
+20.0%
Q4 2021$52,025,000
+60.4%
1,305,520
+45.5%
0.01%
+42.9%
Q3 2021$32,432,000
-23.3%
897,403
-13.1%
0.01%
-30.0%
Q2 2021$42,306,000
+147.3%
1,032,101
+163.2%
0.01%
+150.0%
Q1 2021$17,107,000
-35.2%
392,170
-25.7%
0.00%
-42.9%
Q4 2020$26,414,000
+256.9%
527,760
+200.0%
0.01%
+250.0%
Q3 2020$7,400,000
+401.4%
175,903
+478.6%
0.00%
Q2 2020$1,476,00030,4030.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders